| Trial ID: | L2590 |
| Source ID: | NCT00456144
|
| Associated Drug: |
Gonadotropin Releasing Hormone Agonist Therapy
|
| Title: |
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Prostate Cancer
|
| Interventions: |
DRUG: Gonadotropin Releasing Hormone Agonist Therapy
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Massachusetts General Hospital | Collaborators: National Institutes of Health (NIH)
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
36
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2006-08
|
| Completion Date: |
2012-09
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-11
|
| Locations: |
Massachusetts General Hospital, Boston, Massachusetts, 02215, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00456144
|
